DELANZOMIB
UNII 6IF28942WO

Substance Identification & Data

This profile provides standardized clinical and technical data for Delanzomib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6IF28942WO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 847499-27-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6IF28942WO

CAS Registry Number

847499-27-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DELANZOMIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H28BN3O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SJFBTAPEPRWNKH-CCKFTAQKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C74075

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

24800541

Unique identification number in the NCBI database of chemical substances.

INN ID

9451

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-141

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

OB([C@@H](NC(=O)[C@@H](NC(c1cccc(-c2ccccc2)n1)=O)[C@H](O)C)CC(C)C)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Delanzomib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.